| abstract |
The present disclosure provides methods, nanosensor devices, and uses for in vivo tissue measurement of mitochondrial physiology, including tissue oxygen and other readouts, such as in mitochondrial myopathy, disease, diagnosis, biomarker assessment, and monitoring of interventions and therapies. |